With Particular In Situ Reconstitution Or Modification Of Fuel Moderator Material Patents (Class 376/358)
  • Patent number: 6456680
    Abstract: Inert gaseous fission products, including beryllium, rubidium, and krypton isotopes, resulting from the operation of a uranyl sulfate water solution nuclear reactor are passed through a delaying device to precipitate out strontium-90, then passed to a second delaying device to precipitate out the desired strontium-89.
    Type: Grant
    Filed: March 29, 2000
    Date of Patent: September 24, 2002
    Assignee: TCI Incorporated
    Inventors: S. S. Abalin, Y. I. Vereschagin, G. Y. Grogoriev, V. A. Pavshook, N. N. Ponomarev-Stepnoi, V. E. Khvostionov, D. Yu. Chuvilin
  • Patent number: 5610957
    Abstract: A reactor core coolant flow rate control system for a BWR type nuclear power plant in which electric power is generated by a turbine-driven generator driven by a steam turbine rotating under the work of a main steam generated from a cooling water recirculated through a boiling water reactor includes an internal pump driving unit comprised of an electric motor driven by an electric power generated by the turbine-driven generator, a fluid coupling for transmitting an output torque of the electric motor and a variable-frequency generator whose rotation number is changed in accordance with the torque transmitted by way of the fluid coupling, a fluid coupling control signal generating unit for generating a fluid coupling control signal for the fluid coupling in response to at least one of deviation in a load and a rotation speed of the turbine-driven generator and deviation in a rotation speed of the internal pumps, and a plurality of internal pumps for recirculating the cooling water.
    Type: Grant
    Filed: July 28, 1995
    Date of Patent: March 11, 1997
    Assignees: Hitachi, Ltd., Hitachi Engineering Co., Ltd.
    Inventors: Naoshi Tanikawa, Tetsuya Miyakawa, Hitoshi Sakuma, Toichi Shida, Kimiko Isono
  • Patent number: 5596611
    Abstract: Medical isotopes are produced using a lower power, low cost nuclear reactor which permits the use of all the fission products produced in the reactor. Medical isotopes such as Molybdenum-99 are produced in a reactor operating at a power of 100 to 500 kilowatts.
    Type: Grant
    Filed: November 10, 1994
    Date of Patent: January 21, 1997
    Assignee: The Babcock & Wilcox Company
    Inventor: Russell M. Ball
  • Patent number: 4814046
    Abstract: A process for removing transuranic elements from a waste chloride electrolytic salt containing transuranic elements in addition to rare earth and other fission product elements so the salt waste may be disposed of more easily and the valuable transuranic elements may be recovered for reuse. The salt is contacted with a cadmium-uranium alloy which selectively extracts the transuranic elements from the salt. The waste salt is generated during the reprocessing of nuclear fuel associated with the Integral Fast Reactor (IFR).
    Type: Grant
    Filed: July 12, 1988
    Date of Patent: March 21, 1989
    Assignee: The United States of America as represented by the United States Department of Energy
    Inventors: Terry R. Johnson, John P. Ackerman, Zygmunt Tomczuk, Donald F. Fischer
  • Patent number: 4532102
    Abstract: A method and apparatus are described for the joint production and separation of tritium. Tritium is produced in an aqueous homogenous reactor and heat from the nuclear reaction is used to distill tritium from the lower isotopes of hydrogen.
    Type: Grant
    Filed: June 1, 1983
    Date of Patent: July 30, 1985
    Assignee: The United States of America as represented by the United States Department of Energy
    Inventor: William E. Cawley